Robert L. Camp

16.1k total citations · 4 hit papers
118 papers, 12.8k citations indexed

About

Robert L. Camp is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Robert L. Camp has authored 118 papers receiving a total of 12.8k indexed citations (citations by other indexed papers that have themselves been cited), including 76 papers in Molecular Biology, 56 papers in Oncology and 19 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Robert L. Camp's work include HER2/EGFR in Cancer Research (26 papers), Gene expression and cancer classification (14 papers) and Cell Adhesion Molecules Research (14 papers). Robert L. Camp is often cited by papers focused on HER2/EGFR in Cancer Research (26 papers), Gene expression and cancer classification (14 papers) and Cell Adhesion Molecules Research (14 papers). Robert L. Camp collaborates with scholars based in United States, Canada and Spain. Robert L. Camp's co-authors include David L. Rimm, Marisa Dolled‐Filhart, Gina G. Chung, Harriet M. Kluger, Lori A. Charette, Ellen Puré, Amanda Psyrri, Diane Kowalski, Bruce G. Haffty and Ziwei Yu and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Nature Medicine.

In The Last Decade

Robert L. Camp

118 papers receiving 12.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

X-Tile

2004 2.9k citations Robert L. Camp, Marisa Dolled‐Filhart et al. Clinical Cancer Research profile →
Validation of Tissue Microarray Technology in Breast Carcinoma

2000 655 citations Robert L. Camp, Lori A. Charette et al. Laboratory Investigation profile →
Automated subcellular localization and quantification of protein expression in tissue microarrays

2002 645 citations Robert L. Camp, Gina G. Chung et al. profile →
Molecular Classification Identifies a Subset of Human Papillomavirus–Associated Oropharyngeal Cancers With Favorable Prognosis

2006 618 citations Ziwei Yu, Malini Harigopal et al. profile →

Peers

Countries citing papers authored by Robert L. Camp

Since Specialization

Citations

This map shows the geographic impact of Robert L. Camp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert L. Camp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert L. Camp more than expected).

Fields of papers citing papers by Robert L. Camp

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert L. Camp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert L. Camp. The network helps show where Robert L. Camp may publish in the future.

Co-authorship network of co-authors of Robert L. Camp

This figure shows the co-authorship network connecting the top 25 collaborators of Robert L. Camp. A scholar is included among the top collaborators of Robert L. Camp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert L. Camp. Robert L. Camp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Tumor Microvessel Density as a Prognostic Marker in High-Risk Renal Cell Carcinoma Patients Treated on ECOG-ACRIN E2805 2017 ·Clinical Cancer Research ·Lucia B. Jilaveanu, Mäneka Puligandla, Sarah A. Weiss, Victoria Wang, Christopher R. Zito, Keith T. Flaherty, Marta Boeke, (unknown), Robert L. Camp, Adebowale Adeniran, Michael Pins, Judith Manola, Robert S. DiPaola, Naomi B. Haas, Harriet M. Kluger	24
2	Vascularity of primary and metastatic renal cell carcinoma specimens 2013 ·Journal of Translational Medicine ·Saadia A. Aziz, (unknown), Adebowale Adeniran, John W. Colberg, Robert L. Camp, Harriet M. Kluger	30
3	Punctate LC3B Expression Is a Common Feature of Solid Tumors and Associated with Proliferation, Metastasis, and Poor Outcome 2011 ·Clinical Cancer Research ·Rossitza Lazova, Robert L. Camp, Vincent Klump, Summar Siddiqui, Ravi K. Amaravadi, John M. Pawelek	260
4	Quantitative assessment shows loss of antigenic epitopes as a function of pre-analytic variables 2011 ·Laboratory Investigation ·Yalai Bai, Juliana Tolles, Huan Cheng, Summar Siddiqui, Arun Gopinath, Eirini Pectasides, Robert L. Camp, David L. Rimm, Annette M. Molinaro	52
5	Vertical Targeting of the Phosphatidylinositol-3 Kinase Pathway as a Strategy for Treating Melanoma 2010 ·Clinical Cancer Research ·Saadia A. Aziz, Lucia B. Jilaveanu, Christopher R. Zito, Robert L. Camp, David L. Rimm, Patricia J. Conrad, Harriet M. Kluger	69
6	Analysis of Drosophila Segmentation Network Identifies a JNK Pathway Factor Overexpressed in Kidney Cancer 2009 ·Science ·Jiang Liu, Murad Ghanim, Lei Xue, Christopher D. Brown, Ivan Iossifov, César Angeletti, Sujun Hua, Nicolas Nègre, Michael Ludwig, Thomas Stricker, Hikmat Al‐Ahmadie, Maria Tretiakova, Robert L. Camp, (unknown), David L. Rimm, Tian Xu, Andrey Rzhetsky, K White	98
7	Phosphatidylinositol-3-Kinase as a Therapeutic Target in Melanoma 2009 ·Clinical Cancer Research ·Saadia A. Aziz, Michael A. Davies, Elah Pick, Christopher R. Zito, Lucia B. Jilaveanu, Robert L. Camp, David L. Rimm, Yuval Kluger, Harriet M. Kluger	50
8	C-Raf Is Associated with Disease Progression and Cell Proliferation in a Subset of Melanomas 2009 ·Clinical Cancer Research ·Lucia B. Jilaveanu, Christopher R. Zito, Saadia A. Aziz, Patricia J. Conrad, John C. Schmitz, Mario Sznol, Robert L. Camp, David L. Rimm, Harriet M. Kluger	34
9	Expression of Sorafenib Targets in Melanoma Patients Treated with Carboplatin, Paclitaxel and Sorafenib 2009 ·Clinical Cancer Research ·Lucia B. Jilaveanu, Christopher R. Zito, Sandra J. Lee, Katherine L. Nathanson, Robert L. Camp, David L. Rimm, Keith T. Flaherty, Harriet M. Kluger	33
10	Quantitative multiplexed analysis of ErbB family coexpression for primary breast cancer prognosis in a large retrospective cohort 2009 ·Cancer ·Jennifer M. Giltnane, C. Moeder, Robert L. Camp, David L. Rimm	42
11	Expression of Aurora A (but Not Aurora B) Is Predictive of Survival in Breast Cancer 2008 ·Clinical Cancer Research ·Yasmine Nadler, Robert L. Camp, Candice Schwartz, David L. Rimm, Harriet M. Kluger, Yuval Kluger	110
12	Analysis of p53 protein expression levels on ovarian cancer tissue microarray using automated quantitative analysis elucidates prognostic patient subsets 2007 ·Annals of Oncology ·Amanda Psyrri, Panteleimon Kountourakis, Ziwei Yu, C. Papadimitriou, (unknown), Robert L. Camp, Theofanis Economopoulos, Meletios Α. Dimopoulos	21
13	Classification of Breast Cancer Using Genetic Algorithms and Tissue Microarrays 2006 ·Clinical Cancer Research ·Marisa Dolled‐Filhart, Lisa Rydén, Melissa A. Cregger, Karin Jirström, Malini Harigopal, Robert L. Camp, David L. Rimm	90
14	Vascular endothelial growth factor, FLT‐1, and FLK‐1 analysis in a pancreatic cancer tissue microarray 2006 ·Cancer ·Gina G. Chung, Harry H. Yoon, Maciej P. Zerkowski, Sriparna Ghosh, (unknown), Malini Harigopal, Lori A. Charette, Ronald R. Salem, Robert L. Camp, David L. Rimm, Barbara Burtness	54
15	The Role of Genetic Markers— NAP1L1, MAGE-D2, and MTA1—in Defining Small-Intestinal Carcinoid Neoplasia 2006 ·Annals of Surgical Oncology ·Mark Kidd, Irvin M. Modlin, Shrikant Mane, Robert L. Camp, Geeta N. Eick, Igor Latich	93
16	Role of CCN2/CTGF in the proliferation of Mastomys enterochromaffin-like cells and gastric carcinoid development 2006 ·American Journal of Physiology-Gastrointestinal and Liver Physiology ·Mark Kidd, Irvin M. Modlin, Geeta N. Eick, Robert L. Camp, Shrikant Mane	34
17	β‐Catenin and p53 analyses of a breast carcinoma tissue microarray 2004 ·Cancer ·Gina G. Chung, Maciej P. Zerkowski, Idris Tolgay Ocal, Marisa Dolled‐Filhart, Jung Julie Kang, Amanda Psyrri, Robert L. Camp, David L. Rimm	66
18	Quantitative analysis of breast cancer tissue microarrays shows that both high and normal levels of HER2 expression are associated with poor outcome. 2003 ·PubMed ·Robert L. Camp, Marisa Dolled‐Filhart, Bonnie L. King, David L. Rimm	184
19	Tissue microarray‐based studies of patients with lymph node negative breast carcinoma show that met expression is associated with worse outcome but is not correlated with epidermal growth factor family receptors 2003 ·Cancer ·Idris Tolgay Ocal, Marisa Dolled‐Filhart, Thomas G. D'Aquila, Robert L. Camp, David L. Rimm	81
20	Defective phosphorylation and hyaluronate binding of CD44 with point mutations in the cytoplasmic domain. 1995 ·The Journal of Experimental Medicine ·Ellen Puré, Robert L. Camp, David Peritt, RA Panettieri, Aili L. Lazaar, Sunil Nayak	74

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact